• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第二代H1受体拮抗剂对人嗜碱性粒细胞激活的直接作用。

Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.

作者信息

Ramachers U, Amon U, Wolff H H

机构信息

Department of Dermatology, Medical University of Lübeck, Germany.

出版信息

Agents Actions. 1994 Jun;41 Spec No:C45-6. doi: 10.1007/BF02007760.

DOI:10.1007/BF02007760
PMID:7526656
Abstract

The present study was performed to investigate the putative suppressive effects of H1-receptor antagonists (HRA) of the second generation (astemizole (AS), cetirizine (CT), loratadine (LO), oxatomide (OX) and terfenadine (TF)) on the mediator release from human basophils activated by two classical stimuli. Anti-IgE-mediated histamine release was inhibited in a dose-dependent fashion by TF (maximum inhibitory value: 33.8 +/- 7.6%, 100 microM, n = 7), whereas the other HRA exhibited weaker activity. The anti-IgE-induced LTC4 production was strongly suppressed by TF, LO and OX (92.4 +/- 6.3%, 90.8 +/- 6.0% and 88.5 +/- 5.6%, 100 microM, n = 4-5), while AS was less active (56.4 +/- 4.1%, 100 microM, n = 5). Histamine release induced by incubation with grass pollen antigen (0.01%) was inhibited by TF (40.7 +/- 4.1%, 50 microM, n = 4), but the other HRA showed only low activity. The present findings suggest that some HRA might exhibit direct inhibitory effects on activation of IgE-receptor bearing cells.

摘要

本研究旨在探讨第二代H1受体拮抗剂(HRA)(阿司咪唑(AS)、西替利嗪(CT)、氯雷他定(LO)、奥沙米特(OX)和特非那定(TF))对两种经典刺激激活的人嗜碱性粒细胞介质释放的假定抑制作用。TF以剂量依赖方式抑制抗IgE介导的组胺释放(最大抑制值:33.8±7.6%,100μM,n = 7),而其他HRA活性较弱。TF、LO和OX强烈抑制抗IgE诱导的LTC4产生(92.4±6.3%、90.8±6.0%和88.5±5.6%,100μM,n = 4 - 5),而AS活性较低(56.4±4.1%,100μM,n = 5)。与草花粉抗原(0.01%)孵育诱导的组胺释放被TF抑制(40.7±4.1%,50μM,n = 4),但其他HRA仅显示低活性。本研究结果表明,一些HRA可能对携带IgE受体的细胞激活具有直接抑制作用。

相似文献

1
Direct effects of second-generation H1-receptor antagonists on the activation of human basophils.第二代H1受体拮抗剂对人嗜碱性粒细胞激活的直接作用。
Agents Actions. 1994 Jun;41 Spec No:C45-6. doi: 10.1007/BF02007760.
2
Differential modulation of mediator release from human basophils and mast cells by mizolastine.咪唑斯汀对人嗜碱性粒细胞和肥大细胞介质释放的差异调节作用
Clin Exp Allergy. 2004 Feb;34(2):241-9. doi: 10.1111/j.1365-2222.2004.01851.x.
3
Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine.地氯雷他定治疗对人嗜碱性粒细胞细胞因子生成和介质释放的抑制作用
Clin Exp Allergy. 2001 Sep;31(9):1369-77. doi: 10.1046/j.1365-2222.2001.01130.x.
4
Inhibitory effect of the H1 antagonist loratadine on histamine release from human basophils.H1拮抗剂氯雷他定对人嗜碱性粒细胞组胺释放的抑制作用。
Int Arch Allergy Immunol. 1994 Sep;105(1):12-7. doi: 10.1159/000236797.
5
Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadine.组胺H1拮抗剂去乙氧羰基氯雷他定在体外对人嗜碱性粒细胞中IgE介导和非IgE介导的组胺释放的抑制作用。
J Allergy Clin Immunol. 1994 Feb;93(2):494-500. doi: 10.1016/0091-6749(94)90359-x.
6
Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.奥沙米特抑制人嗜碱性粒细胞和肥大细胞释放促炎介质。
Int Arch Allergy Immunol. 1996 Sep;111(1):23-9. doi: 10.1159/000237340.
7
[Effect of pranlukast on histamine release and leukotriene c4 (ltc4) generation from human peripheral basophils].[普仑司特对人外周血嗜碱性粒细胞组胺释放及白三烯C4(LTC4)生成的影响]
Arerugi. 2004 Jan;53(1):19-23.
8
Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils.特非那定对人血嗜碱性粒细胞和嗜酸性粒细胞介质释放的抑制作用。
Clin Exp Allergy. 1989 Sep;19(5):515-20. doi: 10.1111/j.1365-2222.1989.tb02426.x.
9
Comparison of anti-allergic activities of the histamine H1 receptor antagonists epinastine, ketotifen and oxatomide in human leukocytes.组胺H1受体拮抗剂依匹斯汀、酮替芬和奥沙米特在人白细胞中的抗过敏活性比较。
Arzneimittelforschung. 1995 Jan;45(1):36-40.
10
Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.氯雷他定和去乙氧羰基氯雷他定可抑制人FcεRI⁺细胞介质的免疫释放。
Clin Exp Allergy. 1997 May;27(5):559-67. doi: 10.1046/j.1365-2222.1997.270860.x.

本文引用的文献

1
In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease.抗组胺药对肥大细胞介质释放的体内和体外作用:在过敏性疾病治疗中一项潜在的重要特性。
Ann Allergy. 1989 Nov;63(5):465-9.
2
Antiallergic activity of H1-receptor antagonists assessed by nasal challenge.通过鼻腔激发试验评估H1受体拮抗剂的抗过敏活性。
J Allergy Clin Immunol. 1988 Nov;82(5 Pt 1):881-7. doi: 10.1016/0091-6749(88)90094-2.
3
The pharmacologic modulation of mediator release from human basophils.
J Allergy Clin Immunol. 1988 Sep;82(3 Pt 1):432-8. doi: 10.1016/0091-6749(88)90016-4.
4
The effects of antihistamines beyond H1 antagonism in allergic inflammation.抗组胺药在过敏性炎症中除H1拮抗作用之外的其他作用。
J Allergy Clin Immunol. 1990 Dec;86(6 Pt 2):1019-24. doi: 10.1016/s0091-6749(05)80247-7.
5
Pharmacological studies on the role of protein kinase C in signal transduction of human basophils.
Int Arch Allergy Immunol. 1992;98(4):349-54. doi: 10.1159/000236210.